ArticleBlood advances2026

Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

Mahmoud R Gaballa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.